id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2012-0565-0023,EPA,EPA-HQ-OPP-2012-0565,Registration Review: Tier 2 Drinking Water Assessment for Norflurazon,Supporting & Related Material,Risk Assessment,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:42Z,,0,0,0900006482c85db4
EPA-HQ-OPP-2012-0565-0024,EPA,EPA-HQ-OPP-2012-0565,Registration Review: Preliminary Risk Assessment for Environmental Fate and Ecological Risk for Norflurazon,Supporting & Related Material,Risk Assessment,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:51Z,,0,0,0900006482c85db5
EPA-HQ-OPP-2012-0565-0028,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meeting on August 4, 2016: Recommendations on the Need for an
Immunotoxicity Study (870. 7800).",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:22Z,,0,0,0900006482c86de6
EPA-HQ-OPP-2012-0565-0022,EPA,EPA-HQ-OPP-2012-0565,Registration Reviews: Draft Human Health and/or Ecological Risk Assessments for Several Pesticides,Notice,,2017-12-15T05:00:00Z,2017,12,2017-12-15T05:00:00Z,2018-03-16T03:59:59Z,2018-03-16T01:04:10Z,2017-27098,0,0,0900006482d15818
EPA-HQ-OPP-2012-0565-0025,EPA,EPA-HQ-OPP-2012-0565,Norflurazon: Draft Human Health Risk Assessment in Support of Registration Review.,Supporting & Related Material,Risk Assessment,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:02Z,,0,0,0900006482c85db6
EPA-HQ-OPP-2012-0565-0029,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meetings of July 12, 2012: Recommendations on the requirement of a subchronic inhalation study and the neurotoxicity screening battery for norflurazon.",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:12Z,,0,0,0900006482c86de7
EPA-HQ-OPP-2012-0565-0026,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meeting on June 15, 2017: Recommendations on the Need for Comparative
Thyroid Assay.",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:32Z,,0,0,0900006482c85db7
EPA-HQ-OPP-2012-0565-0030,EPA,EPA-HQ-OPP-2012-0565,Norflurazon (105801) - Label Tracking Report,Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:12Z,,0,0,0900006482c86de8
EPA-HQ-OPP-2012-0565-0027,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meeting on May 18, 2017: Recommendation on the Need for a Dermal Toxicity Study.",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:22Z,,0,0,0900006482c85db8